PTGS2 and cancer: The cytotoxic properties of benzoxazoles against the cancer cells are the results of the inhibition of human topoisomerase II [15], Aurora B kinase [16], other protein kinases [17], cyclooxygenase-2 (COX-2) [18], or the induction of caspase-3 dependent apoptosis [19].